{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T10:32:07Z","timestamp":1779100327277,"version":"3.51.4"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2024YFA1307600"],"award-info":[{"award-number":["2024YFA1307600"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC2308300"],"award-info":[{"award-number":["2023YFC2308300"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007300","name":"China Medical University","doi-asserted-by":"publisher","award":["2023JH2\/20200001"],"award-info":[{"award-number":["2023JH2\/20200001"]}],"id":[{"id":"10.13039\/501100007300","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012131","name":"Department of Science and Technology of Liaoning Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012131","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ijid.2026.108491","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T16:56:01Z","timestamp":1771260961000},"page":"108491","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["SARS-CoV-2 variant specific protective immunity and long-term immune recovery in people living with HIV: a retrospective cohort study"],"prefix":"10.1016","volume":"166","author":[{"given":"Qingqing","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linhong","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haibo","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yonghui","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongzhe","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5333-8943","authenticated-orcid":false,"given":"Hong","family":"Shang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaobo","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxu","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6731","key":"10.1016\/j.ijid.2026.108491_bib0001","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1126\/science.adv8836","article-title":"Don\u2019t pretend COVID-19 didn\u2019t happen","volume":"387","author":"Van Kerkhove","year":"2025","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.ijid.2026.108491_bib0002","doi-asserted-by":"crossref","first-page":"e2005","DOI":"10.1093\/cid\/ciaa1198","article-title":"Risk factors for coronavirus disease 2019 (COVID-19) death in a population cohort study from the Western Cape Province, South Africa","volume":"73","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.ijid.2026.108491_bib0003","doi-asserted-by":"crossref","first-page":"e486","DOI":"10.1016\/S2352-3018(22)00097-2","article-title":"Clinical features of, and risk factors for, severe or fatal COVID-19 among people living with HIV admitted to hospital: analysis of data from the WHO Global Clinical Platform of COVID-19","volume":"9","author":"Bertagnolio","year":"2022","journal-title":"Lancet HIV"},{"issue":"6","key":"10.1016\/j.ijid.2026.108491_bib0004","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.26104","article-title":"COVID-19 among adults living with HIV: correlates of mortality among public sector healthcare users in Western Cape, South Africa","volume":"26","author":"Kassanjee","year":"2023","journal-title":"J Int AIDS Soc"},{"issue":"2","key":"10.1016\/j.ijid.2026.108491_bib0005","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.37069","article-title":"COVID-19 outcomes among persons living with or without diagnosed HIV infection in New York State","volume":"4","author":"Tesoriero","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.ijid.2026.108491_bib0006","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciac237","article-title":"High asymptomatic carriage with the omicron variant in South Africa","volume":"75","author":"Garrett","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.ijid.2026.108491_bib0007","doi-asserted-by":"crossref","first-page":"7240","DOI":"10.1038\/s41467-024-51539-8","article-title":"Rapid intra-host diversification and evolution of SARS-CoV-2 in advanced HIV infection","volume":"15","author":"Ko","year":"2024","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.ijid.2026.108491_bib0008","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.chom.2022.01.005","article-title":"SARS-CoV-2 prolonged infection during advanced HIV disease evolves extensive immune escape","volume":"30","author":"Cele","year":"2022","journal-title":"Cell Host Microbe"},{"issue":"2","key":"10.1016\/j.ijid.2026.108491_bib0009","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/infdis\/jiac343","article-title":"Association between Human Immunodeficiency virus viremia and compromised neutralization of severe acute Respiratory syndrome coronavirus 2 beta variant","volume":"227","author":"Hwa","year":"2023","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.ijid.2026.108491_bib0010","doi-asserted-by":"crossref","first-page":"e857","DOI":"10.1093\/cid\/ciab1008","article-title":"Immunogenicity of severe acute Respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and Ad26.CoV2.S vaccination in people living with Human immunodeficiency virus (HIV)","volume":"75","author":"Khan","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.ijid.2026.108491_bib0011","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.3346\/jkms.2025.40.e28","article-title":"Neutralizing activity and T-cell responses against wild type SARS-CoV-2 virus and Omicron BA.5 variant after ancestral SARS-CoV-2 vaccine booster dose in PLWH receiving ART based on CD4 T-cell count","volume":"40","author":"Ha","year":"2025","journal-title":"J Korean Med Sci"},{"issue":"1","key":"10.1016\/j.ijid.2026.108491_bib0012","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s43856-025-00799-6","article-title":"Long-term immune responses to SARS-CoV-2 Omicron BA.4\/5 mRNA booster in people living with HIV","volume":"5","author":"Augello","year":"2025","journal-title":"Commun Med (Lond)"},{"key":"10.1016\/j.ijid.2026.108491_bib0013","doi-asserted-by":"crossref","first-page":"108189","DOI":"10.1016\/j.ijid.2025.108189","article-title":"Supporting equitable booster strategies: one-year real-world immunogenicity data in people with HIV (PWH) receiving different variant-adapted COVID-19 vaccines","volume":"163","author":"Vergori","year":"2026","journal-title":"Int J Infect Dis"},{"issue":"8","key":"10.1016\/j.ijid.2026.108491_bib0014","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.3390\/ijms26083521","article-title":"Immune response against recent omicron sub-lineages in persons with HIV receiving a protein-based or mRNA XBB.1.5 SARS-CoV-2 booster vaccine","volume":"26","author":"Vergori","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.ijid.2026.108491_bib0015","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jinf.2022.05.026","article-title":"SARS-CoV-2 humoral and cellular immune responses in COVID-19 convalescent individuals with HIV","volume":"85","author":"Giannone","year":"2022","journal-title":"J Infect"},{"issue":"1","key":"10.1016\/j.ijid.2026.108491_bib0016","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciab758","article-title":"Similar antibody responses against severe acute Respiratory syndrome coronavirus 2 in individuals living without and with Human immunodeficiency virus on antiretroviral therapy during the first South African infection wave","volume":"75","author":"Snyman","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.ijid.2026.108491_bib0017","doi-asserted-by":"crossref","first-page":"e334","DOI":"10.1016\/S2352-3018(21)00072-2","article-title":"SARS-CoV-2 seroprevalence, and IgG concentration and pseudovirus neutralising antibody titres after infection, compared by HIV status: a matched case-control observational study","volume":"8","author":"Spinelli","year":"2021","journal-title":"Lancet HIV"},{"issue":"21","key":"10.1016\/j.ijid.2026.108491_bib0018","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.158402","article-title":"Lower SARS-CoV-2-specific humoral immunity in people living with HIV-1 recovered from nonhospitalized COVID-19","volume":"7","author":"Schuster","year":"2022","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.ijid.2026.108491_bib0019","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1186\/s12879-025-11387-3","article-title":"Dynamic monitoring of antibody titers in people living with HIV during Omicron epidemic: comparison between unvaccinated and vaccinated individuals","volume":"25","author":"Halemubieke","year":"2025","journal-title":"BMC Infect Dis"},{"issue":"2","key":"10.1016\/j.ijid.2026.108491_bib0020","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.29446","article-title":"Omicron BA.4\/5 neutralization and cell-mediated immune responses in relation to baseline immune status and breakthrough infection among PLWH: a follow-up cohort study","volume":"96","author":"Zhan","year":"2024","journal-title":"J Med Virol"},{"issue":"11","key":"10.1016\/j.ijid.2026.108491_bib0021","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.70036","article-title":"BIC\/FTC\/TAF benefits people living with HIV after Omicron breakthrough infection in shortening duration of symptoms, enhancing specific immune response and increasing total CD4 cells","volume":"96","author":"Wang","year":"2024","journal-title":"J Med Virol"},{"issue":"10","key":"10.1016\/j.ijid.2026.108491_bib0022","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1021\/acsinfecdis.5c00402","article-title":"A high-throughput broad neutralizing antibody assay for detecting SARS-CoV-2 variant immunity in population","volume":"11","author":"Zhang","year":"2025","journal-title":"ACS Infect Dis"},{"issue":"40","key":"10.1016\/j.ijid.2026.108491_bib0023","article-title":"SARS-CoV-2 evolution: immune dynamics, omicron specificity, and predictive modeling in vaccinated populations","volume":"11","author":"Zhang","year":"2024","journal-title":"Adv Sci (Weinh)"},{"issue":"6","key":"10.1016\/j.ijid.2026.108491_bib0024","doi-asserted-by":"crossref","first-page":"106310","DOI":"10.1016\/j.jinf.2024.106310","article-title":"Synergistic evolution: the dynamic adaptation of SARS-CoV-2 and human protective immunity in the real world","volume":"89","author":"Li","year":"2024","journal-title":"J Infect"},{"issue":"10377","key":"10.1016\/j.ijid.2026.108491_bib0025","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S0140-6736(23)00129-0","article-title":"Characterisation of SARS-CoV-2 variants in Beijing during 2022: an epidemiological and phylogenetic analysis","volume":"401","author":"Pan","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2026.108491_bib0026","unstructured":"World Health Organization. COVID-19 vaccines and people living with HIV. 2023. https:\/\/www.who.int\/news-room\/feature-stories\/detail\/covid-19-vaccines-and-hiv [accessed 10 February 2026]."},{"key":"10.1016\/j.ijid.2026.108491_bib0027","unstructured":"HIV.gov. COVID-19 and people living with HIV. 2025. https:\/\/www.hiv.gov\/hiv-basics\/staying-in-hiv-care\/other-related-health-issues\/coronavirus-covid-19 [accessed 10 February 2026]."},{"issue":"12","key":"10.1016\/j.ijid.2026.108491_bib0028","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.medj.2022.09.010","article-title":"Duration of BA.5 neutralization in sera and nasal swabs from SARS-CoV-2 vaccinated individuals, with or without omicron breakthrough infection","volume":"3","author":"Planas","year":"2022","journal-title":"Med"},{"issue":"8","key":"10.1016\/j.ijid.2026.108491_bib0029","doi-asserted-by":"crossref","first-page":"822","DOI":"10.3390\/diagnostics14080822","article-title":"A multivariant surrogate virus neutralization test demonstrates distinct SARS-CoV-2-specific antibody responses in people living with HIV after a fourth monovalent mRNA vaccination or an omicron breakthrough infection","volume":"14","author":"Springer","year":"2024","journal-title":"Diagnostics (Basel)"},{"issue":"11","key":"10.1016\/j.ijid.2026.108491_bib0030","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1016\/j.cmi.2022.05.018","article-title":"Severe immunosuppression is related to poorer immunogenicity to SARS-CoV-2 vaccines among people living with HIV","volume":"28","author":"Corma-Gomez","year":"2022","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1016\/j.ijid.2026.108491_bib0031","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/s41392-025-02319-3","article-title":"Dynamics of neutralizing antibodies against COVID-19 Omicron subvariants following breakthrough infection in southwest China between December 2022 and April 2024","volume":"10","author":"He","year":"2025","journal-title":"Signal Transduct Target Ther"},{"issue":"5","key":"10.1016\/j.ijid.2026.108491_bib0032","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S1473-3099(23)00181-0","article-title":"SARS-CoV-2 neutralising antibodies after bivalent versus monovalent booster","volume":"23","author":"Wang","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2026.108491_bib0033","doi-asserted-by":"crossref","first-page":"104700","DOI":"10.1016\/j.ebiom.2023.104700","article-title":"Real-world assessment of immunogenicity in immunocompromised individuals following SARS-CoV-2 mRNA vaccination: a one-year follow-up of the prospective clinical trial COVAXID","volume":"94","author":"Chen","year":"2023","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.ijid.2026.108491_bib0034","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28428","article-title":"Booster shot of inactivated SARS-CoV-2 vaccine induces potent immune responses in people living with HIV","volume":"95","author":"Zhan","year":"2023","journal-title":"J Med Virol"},{"issue":"4","key":"10.1016\/j.ijid.2026.108491_bib0035","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/s41579-022-00708-x","article-title":"Towards SARS-CoV-2 serotypes?","volume":"20","author":"Simon-Loriere","year":"2022","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"10.1016\/j.ijid.2026.108491_bib0036","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.hlife.2023.07.002","article-title":"Distinctive serotypes of SARS-related coronaviruses defined by convalescent sera from unvaccinated individuals","volume":"1","author":"Tan","year":"2023","journal-title":"Hlife"},{"issue":"1","key":"10.1016\/j.ijid.2026.108491_bib0037","doi-asserted-by":"crossref","first-page":"8550","DOI":"10.1038\/s41467-024-52668-w","article-title":"Immune escape and attenuated severity associated with the SARS-CoV-2 BA.2.86\/JN.1 lineage","volume":"15","author":"Lewnard","year":"2024","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.ijid.2026.108491_bib0038","doi-asserted-by":"crossref","first-page":"8728","DOI":"10.1038\/s41467-024-53033-7","article-title":"Lineage-specific pathogenicity, immune evasion, and virological features of SARS-CoV-2 BA.2.86\/JN.1 and EG.5\/HK.3","volume":"15","author":"Liu","year":"2024","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.ijid.2026.108491_bib0039","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1001\/jama.2023.27841","article-title":"As COVID-19 cases surge, here\u2019s what to know about JN.1, the latest SARS-CoV-2 \u201cvariant of interest\u201d","volume":"331","author":"Rubin","year":"2024","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ijid.2026.108491_bib0040","doi-asserted-by":"crossref","first-page":"e552","DOI":"10.1093\/cid\/ciac238","volume":"75","author":"Antinori","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.ijid.2026.108491_bib0041","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/nri3447","article-title":"The good, the bad and the ugly \u2013 TFH cells in human health and disease","volume":"13","author":"Tangye","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ijid.2026.108491_bib0042","first-page":"108491","article-title":"Characteristics of humoral and T-cell immune responses in people living with HIV after breakthrough SARS-CoV-2 Omicron variant infection during December 2022 to January 2023","volume":"16","author":"Ding","year":"2026","journal-title":"Virol Sin"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226001268?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226001268?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T04:21:12Z","timestamp":1777609272000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971226001268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":42,"alternative-id":["S1201971226001268"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2026.108491","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SARS-CoV-2 variant specific protective immunity and long-term immune recovery in people living with HIV: a retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2026.108491","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"108491"}}